Acidic pharmaceuticals in domestic wastewater and receiving water from hyper-urbanization city of China (Shanghai): Environmental release and ecological risk

Environmental Science and Pollution Research

Volumn 20, Issue 1, 2013, Pages 108-116

  Duan, Yan Ping ^a   Meng, Xiang Zhou ^a   Wen, Zhi Hao ^a   Chen, Ling ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Acidic pharmaceuticals; Ecological risk; Shanghai; Wastewater

Indexed keywords

ACID; BIODEGRADATION; CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; ENVIRONMENTAL RISK; NATURE-SOCIETY RELATIONS; POLLUTANT REMOVAL; RIVER POLLUTION; SEWAGE TREATMENT; SLUDGE; URBANIZATION;

CHINA; SHANGHAI;

EID: 84871948107     PISSN: 09441344     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11356-012-1000-3     Document Type: Article

References (40)

1. Andreozzi R, Raffaele M, Nicklas P (2003) Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50(10): 1319-1330.
2. Brun GL, Bernier M, Losier R, Doe K, Jackman P, Lee HB (2006) Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ Toxicol Chem 25(8): 2163-2176.
3. Carballa M, Omil F, Lema JM (2007) Calculation methods to perform mass balances of micropollutants in sewage treatment plants. Application to pharmaceutical and personal care products (PPCPs). Environ Sci Technol 41(3): 884-890.
4. Carballa M, Omil F, Lema JM, Llompart M, García-Jares C, Rodríguez I, Gómez M, Ternes T (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38(12): 2918-2926.
5. Castiglioni S, Bagnati R, Fanelli R, Pomati F, Calamari D, Zuccato E (2006) Removal of pharmaceuticals in sewage treatment plants in Italy. Environ Sci Technol 40(1): 357-363.
6. Cirja M, Ivashechkin P, Schäffer A, Corvini PFX (2008) Factors affecting the removal of organic micropollutants from wastewater in conventional treatment plants (CTP) and membrane bioreactors (MBR). Rev Environ Sci Biotechnol 7(1): 61-78.
7. Cleuvers M (2003) Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142(3): 185-194.
8. CMEIN (2005) Chinese medical statistical yearbook. Products section, Beijing, China.
9. Flaherty CM, Dodson SI (2005) Effects of pharmaceuticals on Daphnia survival, growth, and reproduction. Chemosphere 61(2): 200-207.
10. Gagnon C, Lajeunesse A, Cejka P, Gagné F, Hausler R (2008) Degradation of selected acidic and neutral pharmaceutical products in a primary-treated wastewater by disinfection processes. Ozone Sci Eng 30(5): 387-92.
11. Grung M, Kallqvist T, Sakshaug S, Skurtveit S, Thomas KV (2008) Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicol Environ Saf 71(2): 328-340.
12. Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131(1-2): 5-17.
13. Hernando MD, Mezcua M, Fernandez-Alba AR, Barcelo D (2006) Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69(2): 334-342.
14. Huang QX, Yu YY, Tang CM, Zhang K, Cui JL, Peng XZ (2011) Occurrence and behavior of non-steroidal anti-inflammatory drugs and lipid regulators in wastewater and urban river water of the Pearl River Delta, South China. J Environ Monit 13(4): 855-863.
15. Jelic A, Gros M, Ginebreda A, Cespedes-Sanchez R, Ventura F, Petrovic M, Barcelo D (2011) Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res 45(3): 1165-1176.
16. Jones OAH, Voulvoulis N, Lester JN (2007) The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment. Environ Pollut 145(3): 738-744.
17. Kimura K, Hara H, Watanabe Y (2007) Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. Environ Sci Technol 41(10): 3708-3714.
18. Lindqvist N, Tuhkanen T, Kronberg L (2005) Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res 39(11): 2219-2228.
19. Lishman L, Smyth SA, Sarafin K, Kleywegt S, Toito J, Peart T, Lee B, Servos M, Beland M, Seto P (2006) Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci Total Environ 367(2-3): 544-558.
20. Nakada N, Tanishima T, Shinohara H, Kiri K, Takada H (2006) Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res 40(17): 3297-3303.
21. Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, Shivaprasad HL, Ahmed S, Chaudhry MJI, Arshad M, Mahmood S, Ali A, Khan AA (2004) Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427(6975): 630-633.
22. Peng XZ (2011) China's demographic history and future challenges. Science 333(6042): 581-587.
23. Ra JS, Oh SY, Lee BC, Kim SD (2008) The effect of suspended particles coated by humic acid on the toxicity of pharmaceuticals, estrogens, and phenolic compounds. Environ Int 34(2): 184-192.
24. Radjenović J, Petrović M, Barceló D (2007) Advanced mass, spectrometric methods applied to the study of fate and removal of pharmaceuticals in wastewater treatment. Trends Anal Chem 26(11): 1132-1144.
25. Roberts PH, Thomas KV (2006) The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Total Environ 356(1-3): 143-153.
26. Santos JL, Aparicio I, Alonso E (2007) Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ Int 33(4): 596-601.
27. Tauxe-Wuersch A, De Alencastro LF, Grandjean D, Tarradellas J (2005) Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 39(9): 1761-1772.
28. Ternes TA (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32(11): 3245-3260.
29. Ternes TA, Bonerz M, Herrmann N, Löffler D, Keller E, Làcida BB, Alder AC (2005) Determination of pharmaceuticals, iodinated contrast media and musk fragrances in sludge by LC/tandem MS and GC/MS. J Chromatogr A 1067(1-2): 213-223.
30. Ternes TA, Meisenheimer M, McDowell D, Sacher F, Brauch HJ, Gulde BH, Preuss G, Wilme U, Seibert NZ (2002) Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 36(17): 3855-3863.
31. Thomas PM, Foster GD (2005) Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process. Environ Toxicol Chem 24(1): 25-30.
32. Tixier C, Singer HP, Oellers S, Müller SR (2003) Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ Sci Technol 37(6): 1061-1068.
33. Vieno N, Tuhkanen T, Kronberg L (2007a) Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res 41(5): 1001-1012.
34. Vieno NM, Härkki H, Tuhkanen T, Kronberg L (2007b) Occurrence of pharmaceuticals in river water and their elimination a pilot-scale drinking water treatment plant. Environ Sci Technol 41(14): 5077-5084.
35. Vieno NM, Tuhkanen T, Kronberg L (2005) Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Technol 39(21): 8220-8226.
36. Wang L, Ying GG, Zhao JL, Yang XB, Chen F, Tao R, Liu S, Zhou LJ (2010) Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China. Sci Total Environ 408(16): 3139-3147.
37. Yang C, Meng XZ, Chen L, Xia SQ (2011a) Polybrominated diphenyl ethers in sewage sludge from Shanghai, China: possible ecological risk applied to agricultural land. Chemosphere 85(3): 418-423.
38. Yang Y, Fu J, Peng H, Hou L, Liu M, Zhou JL (2011b) Occurrence and phase distribution of selected pharmaceuticals in the Yangtze Estuary and its coastal zone. J Hazard Mater 190(1-3): 588-596.
39. Zhao JL, Ying GG, Liu YS, Chen F, Yang JF, Wang L, Yang XB, Stauber JL, Warne MS (2010) Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China. Environ Toxicol Chem 29(6): 1377-1384.
40. Zorita S, Martensson L, Mathiasson L (2009) Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Sci Total Environ 407(8): 2760-2770.